Pontifax VI G.P. L.P. 13D and 13G filings for Nuvectis Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-05 10:55 am Sale | 2024-09-30 | 13G | NUVECTIS PHARMA INC NVCT | Pontifax VI G.P. L.P. | 288,873 1.500% | -628,527 (-68.51%) | Filing |
| 2024-02-06 08:47 am Purchase | 2023-12-31 | 13G | NUVECTIS PHARMA INC NVCT | Pontifax VI G.P. L.P. | 917,400 5.300% | 917,400 (New Position) | Filing |